We are live on ! Find out more
CWG

C WorldWide Group Portfolio holdings

AUM $4.66B
1-Year Est. Return 11.67%
This Fund
S&P 500
This Quarter Est. Return
+9.6%
1 Year Est. Return
+11.67%
3 Year Est. Return
+62.16%
5 Year Est. Return
+69.96%
10 Year Est. Return
+372.2%
AUM
$9.98B
AUM Growth
+$1.09B
Cap. Flow
+$323M
Cap. Flow %
3.24%
Top 10 Hldgs %
71.22%
Holding
97
New
4
Increased
29
Reduced
16
Closed
3

Top Buys

Rank Stock Value
1
SPGI icon
S&P Global
SPGI
+$134M
2
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$34.7M
3
IBN icon
ICICI Bank
IBN
+$21.1M
4
V icon
Visa
V
+$19.4M
5
IRTC icon
iRhythm Holdings
IRTC
+$18.2M

Top Sells

Rank Stock Value
1
HDB icon
HDFC Bank
HDB
+$19.8M
2
MYOK
MyoKardia, Inc. Common Stock
MYOK
+$15.9M
3
EXAS
Exact Sciences
EXAS
+$11.5M
4
SE icon
Sea Limited
SE
+$11.4M
5
NVCR icon
NovoCure
NVCR
+$10.9M

Sector Composition

Rank Sector Weight
1 Financials 18.51%
2 Consumer Discretionary 17.07%
3 Healthcare 16.4%
4 Consumer Staples 10.48%
5 Technology 9.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DXCM icon
26
DexCom
DXCM
$29.2B
$35.9M 0.36%
388,000
+140,000
+56% +$12.5M
EDU icon
27
New Oriental
EDU
$9.12B
$34.5M 0.35%
185,582
+2,369
+1% +$399K
ISRG icon
28
Intuitive Surgical
ISRG
$127B
$34.3M 0.34%
125,811
– –
HZNP
29
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$34.1M 0.34%
+466,544
New +$34.7M
TAL icon
30
TAL Education Group
TAL
$6.02B
$33.3M 0.33%
465,254
+196,902
+73% +$14.2M
EW icon
31
Edwards Lifesciences
EW
$49.3B
$31.1M 0.31%
341,311
– –
NVCR icon
32
NovoCure
NVCR
$1.78B
$28M 0.28%
161,784
-80,000
-33% -$10.9M
HRTX icon
33
Heron Therapeutics
HRTX
$92.5M
$25.4M 0.25%
1,202,069
+300,000
+33% +$5.21M
CNC icon
34
Centene
CNC
$31.3B
$24.9M 0.25%
414,756
– –
QDEL icon
35
QuidelOrtho
QDEL
$1.13B
$24.3M 0.24%
135,000
-15,000
-10% -$3.33M
TFX icon
36
Teleflex
TFX
$5.9B
$23.9M 0.24%
58,000
– –
LHCG
37
DELISTED
LHC Group LLC
LHCG
$23.6M 0.24%
110,657
– –
ILMN icon
38
Illumina
ILMN
$29.2B
$21.5M 0.21%
59,601
– –
VRTX icon
39
Vertex Pharmaceuticals
VRTX
$125B
$20.9M 0.21%
88,557
+20,000
+29% +$4.59M
SRPT icon
40
Sarepta Therapeutics
SRPT
$1.63B
$20.5M 0.21%
120,329
-25,000
-17% -$3.7M
AXNX
41
DELISTED
Axonics, Inc. Common Stock
AXNX
$20M 0.2%
400,000
– –
AERI
42
DELISTED
Aerie Pharmaceuticals
AERI
$19.7M 0.2%
1,456,142
– –
IRTC icon
43
iRhythm Holdings
IRTC
$3.96B
$19M 0.19%
+80,000
New +$18.2M
PODD icon
44
Insulet
PODD
$11.8B
$18.6M 0.19%
72,908
– –
GKOS icon
45
Glaukos
GKOS
$9.32B
$18.6M 0.19%
247,212
– –
CHRS icon
46
Coherus Oncology
CHRS
$219M
$18.4M 0.18%
1,058,464
– –
BHVN
47
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$16.1M 0.16%
187,498
-64,253
-26% -$5.44M
MRK icon
48
Merck
MRK
$326B
$15.3M 0.15%
195,691
– –
ALGN icon
49
Align Technology
ALGN
$12.8B
$15.2M 0.15%
28,428
– –
BMRN icon
50
BioMarin Pharmaceuticals
BMRN
$12B
$14.4M 0.14%
163,851
– –
1
2
3 4

Similar funds

ASC
Atalanta Sosnoff Capital New York $4.66B AUM 41.34% 1-Year Est. Return
MA
Mutual Advisors Omaha, Nebraska $4.67B AUM 17.48% 1-Year Est. Return
KCM
Kornitzer Capital Management Shawnee Mission, Kansas $4.65B AUM 23.83% 1-Year Est. Return
EI
EFG International Zurich $4.67B AUM
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
VCM
Voleon Capital Management Berkeley, California $4.64B AUM 38.78% 1-Year Est. Return
LPPI
Local Pensions Partnership Investment London, United Kingdom $4.63B AUM 13.51% 1-Year Est. Return
CCWM
Cassaday & Co Wealth Management Mclean, Virginia $4.69B AUM 20.56% 1-Year Est. Return

C WorldWide Group's Q4 2020 Portfolio in Review

As of Q4 2020, C WorldWide Group held 97 positions worth $9.98B, up 12% from $8.89B the previous quarter. Its ten largest holdings account for 71% of the portfolio.

C WorldWide Group deployed $323M of net new capital in Q4 2020, opening 4 new positions and adding to 29 existing holdings. Its largest new stake was Horizon Therapeutics Public Limited Company Ordinary Shares: 466,544 shares worth $34.1M.

By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was HDFC Bank, an estimated $19.8M trimmed.

  • C WorldWide Group's largest Q4 2020 buy was Horizon Therapeutics Public Limited Company Ordinary Shares: 466,544 shares worth $34.1M.
  • C WorldWide Group added most to S&P Global in Q4 2020, an estimated $134M increase.
  • C WorldWide Group's biggest Q4 2020 reduction was HDFC Bank, cutting an estimated $19.8M.
  • C WorldWide Group fully exited MyoKardia, Inc. Common Stock in Q4 2020, selling an estimated $15.9M.
  • C WorldWide Group's ten largest holdings make up 71% of its $9.98B portfolio in Q4 2020.
  • C WorldWide Group opened 4 new positions and closed 3 in Q4 2020.
  • C WorldWide Group's portfolio value rose 12% quarter-over-quarter to $9.98B.

Based on C WorldWide Group's 13F filing for Q4 2020, filed 5 Feb 2021.